contraceptive pills_AS_247x165

Independent professional body guideline

FSRH CHC guideline

2022-01-10T10:25:00+00:00By

This concise updated summary of the FSRH combined hormonal contraception guideline covers use, effectiveness, non-contraceptive benefits, and risks

contraceptive methods_254409397_JPC-PROD

Independent professional body guideline

FSRH overweight, obesity, and contraception guideline

2021-10-01T15:05:00+01:00By

Covering evidence-based recommendations on the provision of contraception to women who are overweight or obese

AdobeStock_142527699

Independent professional body guideline

BSPID/EFP oral health and pregnancy guideline

2021-06-25T08:07:00+01:00By British Society of Periodontology and Implant Dentistry, European Federation of Periodontology

A short, useful summary of key oral health recommendations for pregnant women from the British Society of Periodontology

hands holding pills

Independent professional body guideline

FSRH emergency contraception guideline

2021-01-04T14:34:00+00:00By

This summary of FSRH EC guidance compares the effectiveness of EC methods and decision-making based on patients’ needs, including helpful algorithms.

urine infection

SIGN guideline

SIGN guideline on bacterial UTIs in women

2020-11-16T13:42:00+00:00By

This guidance provides advice on the managment of suspected bacterial lower urinary tract infection in adult women

checklist

Independent professional body guideline

FSRH UKMEC contraception guideline

2020-06-23T00:00:00+01:00By

A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.

AdobeStock_247826679

NICE guideline

NICE CKS candida—female genital

2020-04-02T14:04:00+01:00By

This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting.

Nurse and pregnant woman_AS resized

PHE/DH/DWP guideline

PHE vaccination in pregnancy guideline

2020-01-30T08:17:00+00:00By

This section is part 6 of the PHE UK immunisation schedule.

Doctor explaining diagnosis to woman pointing at laptop

NICE guideline

NICE menopause guideline

2019-12-19T00:00:00+00:00By

This summary covers diagnosis, treatment options, and includes a useful care algorithm for the management of menopause.

Doctor In Consultation With Female Patient In Office

NICE guideline

NICE recommendations for women with urinary incontinence

2019-06-29T08:33:00+01:00By

Summary of NICE guidance covers history taking, assessing urinary incontinence, investigations, non-surgical management, and indicators for referral

Resource hub

  • Making the case for preconception care

  • Having a smear test—what is it about?

  • Human papillomavirus (HPV) vaccination and cervical cancer—addressing the myths

  • Your guide to staying active in pregnancy

  • Pain and symptom diary

Educational resources

20220124 HRT video SPIN block_V.1

Hormone replacement therapy (HRT): what is the role of the progestogen?

Commissioned by Viatris

This promotional video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Intended for UK healthcare professionals. Products and brand names are mentioned. View Femoston® (estradiol/dydrogesterone) and Femoston® -conti (estradiol/dydrogesterone) prescribing and adverse event reporting information.
FEM-2021-0362 March 2022

20220124 On demand HRT webinar SPIN block_V.1

Hormone replacement therapy (HRT): Overview and focus on progestogens

Commissioned by Viatris

This promotional webinar has been commissioned and funded by Viatris and developed in partnership with Guidelines. Intended for UK healthcare professionals. Products and brand names are mentioned. View Femoston® (estradiol/dydrogesterone) and Femoston® -conti (estradiol/dydrogesterone) prescribing and adverse event reporting information.
FEM-2021-0346 March 2022

Viatris HRT algorithm supplement_Index image

Prescribing combined hormone replacement therapy (HRT) containing dydrogesterone

Commissioned by Viatris

This promotional algorithm has been commissioned and funded by Viatris and developed in partnership with Guidelines. Intended for UK healthcare professionals.
View Femoston® (estradiol/dydrogesterone) and Femoston® -conti (estradiol/dydrogesterone) prescribing and adverse event reporting information.
FEM-2021-0238 June 2021

Preconception advice

Women of child-bearing age with inflammatory rheumatic diseases guideline

By Working party—Giles Allen Nelson-Piercy Tower Warburton Gordon

This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.